Home › Stocks › VRXA › Changes

Who bought & sold VRXA (Q2 2026)

Funds holding (Q2 2026)9
New positions9
Added0
Reduced0
Exited0

As of Q2 2026, 9 institutional funds reported holding VRXA (Veraxa Biotech AG): 9 opened new positions, 0 added, 0 trimmed and 0 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (9)

Fund Shares Value Weight
UBS Group AG New 157.24K $295.61K —
GEODE CAPITAL MANAGEMENT, LLC New 119.77K $225.16K —
Geode Capital Management New 119.77K $225.16K —
HRT FINANCIAL LP New 18.87K $35.00K —
SUSQUEHANNA INTERNATIONAL GROUP, LLP New 10.83K $20.37K —
PICTON MAHONEY ASSET MANAGEMENT New 175.00K $19.30K —
WOLVERINE ASSET MANAGEMENT LLC New 1.75K $3.29K —
JPMorgan Chase & Co New 396 $859 —
Caitong International Asset Management Co., Ltd New 6 $11 —

Added to positions (0)

No adds this quarter.

Reduced positions (0)

No trims this quarter.

Exited positions (0)

No exits this quarter.